These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7706525)

  • 61. Lipoprotein (a) and stroke.
    Milionis HJ; Winder AF; Mikhailidis DP
    J Clin Pathol; 2000 Jul; 53(7):487-96. PubMed ID: 10961170
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Biological factors affecting concentrations of serum LpAI lipoprotein particles in serum, and determination of reference limits.
    Steinmetz J; Choukaife A; Visvikis S; Henny J; Siest G
    Clin Chem; 1990 Apr; 36(4):677-80. PubMed ID: 2108826
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Plasma lipids and interleukins in geriatric patients with ischemic heart disease].
    Berezhnova IA; Korshunov GV
    Klin Lab Diagn; 2009 Aug; (8):3-6. PubMed ID: 19827189
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A discrimination value of serum lipid level on the basis of healthy and diseased persons.
    Okada M; Okada M; Yakata M
    Med Inform (Lond); 1988; 13(2):81-92. PubMed ID: 3405019
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Increased concentrations of serum lipoprotein (a) in response to growth hormone treatment.
    Olivecrona H; Ericsson S; Berglund L; Angelin B
    BMJ; 1993 Jun; 306(6894):1726-7. PubMed ID: 8343630
    [No Abstract]   [Full Text] [Related]  

  • 66. Plasma lipoprotein(a) concentrations are not elevated by cardiopulmonary bypass.
    Moliterno DJ; Jessen ME; Schueler K; Cohen J
    Atherosclerosis; 1993 Dec; 104(1-2):223-5. PubMed ID: 8141847
    [No Abstract]   [Full Text] [Related]  

  • 67. Measuring lipoprotein(a): do it without ifs and buts.
    Kronenberg F
    Eur J Prev Cardiol; 2022 May; 29(5):766-768. PubMed ID: 34718514
    [No Abstract]   [Full Text] [Related]  

  • 68. ACP Broad Sheet no 151: September 1997. Investigation of dyslipidaemias.
    Winder AF; Richmond W; Vallance DT
    J Clin Pathol; 1997 Sep; 50(9):721-34. PubMed ID: 9389972
    [No Abstract]   [Full Text] [Related]  

  • 69. Apolipoproteins A-I, A-II and B, lipoprotein(a) and the risk of ischaemic heart disease: the Caerphilly study.
    Sweetnam PM; Bolton CH; Downs LG; Durrington PN; MacKness MI; Elwood PC; Yarnell JW
    Eur J Clin Invest; 2000 Nov; 30(11):947-56. PubMed ID: 11114956
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The effect of endurance exercise training on plasma lipoprotein AI and lipoprotein AI:AII concentrations in sedentary adults.
    Wilund KR; Colvin PL; Phares D; Goldberg AP; Hagberg JM
    Metabolism; 2002 Aug; 51(8):1053-60. PubMed ID: 12145781
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Lipoprotein(a) is a potential coronary risk factor.
    Fujino A; Watanabe T; Kunii H; Yamaguchi N; Yoshinari K; Watanabe Y; Mutou M; Ishikawa S; Ogyuu A; Ashikawa K; Maruyama Y
    Jpn Circ J; 2000 Jan; 64(1):51-6. PubMed ID: 10651207
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Lipoprotein(a) mass: a massively misunderstood metric.
    McConnell JP; Guadagno PA; Dayspring TD; Hoefner DM; Thiselton DL; Warnick GR; Harris WS
    J Clin Lipidol; 2014; 8(6):550-553. PubMed ID: 25499936
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Limited discriminant value of lipoprotein AI, lipoprotein Lp(a) and other lipoprotein particles in patients with and without early onset ischaemic heart disease.
    Vallance DT; Staunton HA; Winder AF
    J Clin Pathol; 1995 Jan; 48(1):70-4. PubMed ID: 7706525
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Brisk walking and serum lipoprotein variables in formerly sedentary men aged 42-59 years.
    Stensel DJ; Hardman AE; Brooke-Wavell K; Vallance D; Jones PR; Norgan NG; Winder AF
    Clin Sci (Lond); 1993 Dec; 85(6):701-8. PubMed ID: 8287662
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Unrecognized dyslipoproteinemia in United Kingdom families recruited to a genetic register because of unexplained coronary heart disease.
    Staunton A; Vallance DT; Child A; Camm AJ; Winder AF
    J Lab Clin Med; 1994 Jun; 123(6):842-8. PubMed ID: 8201262
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Concentrations of apolipoprotein A-I-containing particles in patients with hypoalphalipoproteinemia.
    Montali A; Vega GL; Grundy SM
    Arterioscler Thromb; 1994 Apr; 14(4):511-7. PubMed ID: 8148349
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prevalence of coronary heart disease in the Framingham Offspring Study: role of lipoprotein cholesterols.
    Wilson PW; Garrison RJ; Castelli WP; Feinleib M; McNamara PM; Kannel WB
    Am J Cardiol; 1980 Oct; 46(4):649-54. PubMed ID: 7416024
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins].
    Sniderman A; Shapiro S; Marpole D; Skinner B; Teng B; Kwiterovich PO
    Proc Natl Acad Sci U S A; 1980 Jan; 77(1):604-8. PubMed ID: 6928647
    [TBL] [Abstract][Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.